• Elderly man sitting with a younger blonde-haired woman learning how to use a smart tablet

OncoVAX® is an autologous cancer vaccine manufactured with a patented process to leverage a patient’s own tumor cells to launch a potent and customized immune response against residual cancer cells that may reside in the body after surgery.  Killing these residual cells is key to preventing the recurrence of the cancer.